A Look at Promising Strategies to Improve CAR T-Cell Therapy Access
A Look at Promising Strategies to Improve CAR T-Cell Therapy Access from Patient Empowerment Network on Vimeo. How can CAR T-cell therapy access be improved? Expert Dr. Krina Patel from…
Are There Myeloma Trials Investigating CAR T for Frontline Therapy?
Are There Myeloma Trials Investigating CAR T for Frontline Therapy? from Patient Empowerment Network on Vimeo. Is it possible for CAR T-cell therapy to be used as a frontline therapy?…
How Can Variable Patient Groups Be Addressed in CAR T?
https://vimeo.com/944065239 Can CAR T-cell therapy address variable patient groups? Expert Dr. Krina Patel from The University of Texas MD Anderson Cancer Center discusses variances in different myeloma patient groups, the KarMMa-3 study,…
What Patient Types Are Good Candidates for CAR T-Cell Therapy?
What Patient Types Are Good Candidates for CAR T-Cell Therapy? from Patient Empowerment Network on Vimeo. For CAR T-cell therapy, what patient types are good candidates? Expert Dr. Krina Patel…
Dr. Krina Patel: Why Is It Important for You to Empower Patients?
Dr. Krina Patel: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Why is it important to empower patients in their care? Expert Dr….
Understanding Myeloma | How You Can Collaborate in Your Care
https://vimeo.com/942111089 This animated video reviews the types of myeloma, essential testing following a myeloma diagnosis, and advice for working with your healthcare team for the best overall care. See More…
Dr. Eugene Manley: Why Is It Important for You to Empower Patients?
Dr. Eugene Manley: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Drawing from his experiences interacting with patients, survivors, and caregivers, Dr. Eugene…
Dr. Joshua Sabari: Why Is It Important for You to Empower Patients?
Dr. Joshua Sabari: Why Is It Important for You to Empower Patients? from Patient Empowerment Network on Vimeo. Dr. Joshua Sabari emphasizes the importance of active listening and non-judgmental communication…
How Can We Leverage Lung Cancer Biomarker Data to Address Health Disparities
https://vimeo.com/940980348 How can biomarker disparities be overcome by data collection? Experts Dr. Joshua Sabari from NYU Langone and Dr. Eugene Manley from SCHEQ Foundation discuss the status of biomarker data…
Lung Cancer Biomarker Disparities | How Precision Medicine and Research Can Help
https://vimeo.com/940980427 How can lung cancer research and precision medicine help with biomarker disparities? Experts Dr. Joshua Sabari from NYU Langone and Dr. Eugene Manley from SCHEQ Foundation discuss testing factors…
Maximizing Biomarker Equity: Leveraging Partnerships to Close Biomarker Disparities in Lung Cancer
https://vimeo.com/940980528 How can biomarker disparities be minimized by lung cancer partnerships? Expert Dr. Eugene Manley from SCHEQ Foundation discusses individuals, lung cancer partnerships, and how partners can work collaboratively toward…
Hope Unleashed: Advancing Therapies for Defiant Mutations in Lung Cancer
https://vimeo.com/940980556 What promising studies in lung cancer mutations are there that patients should know about? Expert Dr. Joshua Sabari from NYU Langone discusses common lung cancer mutations, incidence rates, promising…